{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:22:03Z","timestamp":1772119323956,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:00:00Z","timestamp":1624924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:00:00Z","timestamp":1624924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s00432-021-03699-z","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T10:27:09Z","timestamp":1624962429000},"page":"1153-1158","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multi-institutional survey of malignant pleural mesothelioma patients in the Hokushin region"],"prefix":"10.1007","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4451-4225","authenticated-orcid":false,"given":"Hidetaka","family":"Uramoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoya","family":"Takiguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonobu","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azusa","family":"Tanimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuji","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yozo","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ichi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsutoshi","family":"Nakada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Hirono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikazu","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Yano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,29]]},"reference":[{"key":"3699_CR1","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0140-6736(20)32714-8","volume":"397","author":"P Baas","year":"2021","unstructured":"Baas P, Scherpereel A, Nowak AK, Fujimoto N, Peters S, Tsao AS et al (2021) First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial. Lancet 397:375\u2013386","journal-title":"Lancet"},{"key":"3699_CR2","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.lungcan.2015.03.005","volume":"88","author":"P Beckett","year":"2015","unstructured":"Beckett P, Edwards J, Fennell D, Hubbard R, Woolhouse I, Peake MD (2015) Demographics, management and survival of patients with malignant pleural mesothelioma in the National Lung Cancer Audit in England and Wales. Lung Cancer 88:344\u2013348","journal-title":"Lung Cancer"},{"key":"3699_CR3","doi-asserted-by":"publisher","first-page":"82","DOI":"10.4103\/0019-5278.146897","volume":"18","author":"C Bianchi","year":"2014","unstructured":"Bianchi C, Bianchi T (2014) Global mesothelioma epidemic: trend and features. Indian J Occup Environ Med 18:82\u201388","journal-title":"Indian J Occup Environ Med"},{"key":"3699_CR4","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/S1470-2045(20)30606-9","volume":"22","author":"BCJ Cho","year":"2021","unstructured":"Cho BCJ, Donahoe L, Bradbury PA, Leighl N, Keshavjee S, Hope A et al (2021) Surgery for malignant pleural mesothelioma after radiotherapy (SMART): final results from a single-centre, phase 2 trial. Lancet Oncol 22:190\u2013197","journal-title":"Lancet Oncol"},{"key":"3699_CR5","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/j.1349-7006.2011.02165.x","volume":"103","author":"K Gemba","year":"2012","unstructured":"Gemba K, Fujimoto N, Kato K, Aoe K, Takeshima Y, Inai K et al (2012) National survey of malignant mesothelioma and asbestos exposure in Japan. Cancer Sci 103:483\u2013490","journal-title":"Cancer Sci"},{"key":"3699_CR6","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s11748-007-0243-2","volume":"56","author":"S Hasegawa","year":"2008","unstructured":"Hasegawa S, Tanaka F (2008) Malignant mesothelioma: current status and perspective in Japan and the world. Gen Thorac Cardiovasc Surg 56:317\u2013323","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"3699_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1179\/2049396712Y.0000000016","volume":"19","author":"SJ Henley","year":"2013","unstructured":"Henley SJ, Larson TC, Wu M, Antao VC, Lewis M, Pinheiro GA et al (2013) Mesothelioma incidence in 50 states and the District of Columbia, United States, 2003\u20132008. Int J Occup Environ Health 19:1\u201310","journal-title":"Int J Occup Environ Health"},{"key":"3699_CR8","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/ajim.20868","volume":"53","author":"T Kishimoto","year":"2010","unstructured":"Kishimoto T, Gemba K, Fujimoto N, Aoe K, Kato K, Takeshima Y et al (2010) Clinical study on mesothelioma in Japan: relevance to occupational asbestos exposure. Am J Ind Med 53:1081\u20131087","journal-title":"Am J Ind Med"},{"key":"3699_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2486\/indhealth.37.9","volume":"37","author":"N Kurumatani","year":"1999","unstructured":"Kurumatani N, Natori Y, Mizutani R, Kumagai S, Haruta M, Miura H et al (1999) A historical cohort mortality study of workers exposed to asbestos in a refitting shipyard. Ind Health 37:9\u201317","journal-title":"Ind Health"},{"key":"3699_CR10","first-page":"718","volume":"34","author":"BP Lanphear","year":"1992","unstructured":"Lanphear BP, Buncher CR (1992) Latent period for malignant mesothelioma of occupational origin. J Occup Med 34:718\u2013721","journal-title":"J Occup Med"},{"key":"3699_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2486\/indhealth.39.65","volume":"39","author":"K Morinaga","year":"2001","unstructured":"Morinaga K, Kishimoto T, Sakatani M, Akira M, Yokoyama K, Sera Y (2001) Asbestos-related lung cancer and mesothelioma in Japan. Ind Health 39:65\u201374","journal-title":"Ind Health"},{"key":"3699_CR12","first-page":"20200144","volume":"6","author":"DC Murphy","year":"2020","unstructured":"Murphy DC, Mount A, Starkie F, Taylor L, Aujayeb A (2020) A review of malignant pleural mesothelioma in a large North East UK pleural centre. Pleura Peritoneum 6:20200144","journal-title":"Pleura Peritoneum"},{"key":"3699_CR13","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/sj.bjc.6601638","volume":"90","author":"C Pelucchi","year":"2004","unstructured":"Pelucchi C, Malvezzi M, La Vecchia C, Levi F, Decarli A, Negri E (2004) The Mesothelioma epidemic in Western Europe: an update. Br J Cancer 90:1022\u20131024","journal-title":"Br J Cancer"},{"key":"3699_CR14","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1634\/theoncologist.2010-0185","volume":"16","author":"A Price","year":"2011","unstructured":"Price A (2011) What is the role of radiotherapy in malignant pleural mesothelioma? Oncologist 16:359\u2013365","journal-title":"Oncologist"},{"key":"3699_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/978-3-642-10862-4_7","volume":"189","author":"D Rice","year":"2011","unstructured":"Rice D (2011) Surgical therapy of mesothelioma. Recent Results Cancer Res 189:97\u2013125","journal-title":"Recent Results Cancer Res"},{"key":"3699_CR16","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/S0140-6736(14)60418-9","volume":"384","author":"RC Rintoul","year":"2014","unstructured":"Rintoul RC, Ritchie AJ, Edwards JG, Waller DA, Coonar AS, Bennett M et al (2014) Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open-label, randomised, controlled trial. Lancet 384:1118\u20131127","journal-title":"Lancet"},{"key":"3699_CR17","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.21037\/jtd.2018.03.53","volume":"10","author":"Y Shintani","year":"2018","unstructured":"Shintani Y, Hasegawa S, Takuwa T, Aoe K, Kato K, Fujimoto N et al (2018) Prospective registry database of patients with malignant mesothelioma: directions for a future Japanese registry-based lung cancer study. J Thorac Dis 10:1968\u20131971","journal-title":"J Thorac Dis"},{"key":"3699_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-021-03620-8","author":"H Uramoto","year":"2021","unstructured":"Uramoto H, Takiguchi T, Koizumi T, Tanimoto A, Hayashi R, Nakazawa Y, Ito KI, Nakada M, Hirono Y, Nishino Y, Yano S (2021) Multi-institutional survey of thymic carcinoma patients in Hokushin region. J Cancer Res Clin Oncol. https:\/\/doi.org\/10.1007\/s00432-021-03620-8","journal-title":"J Cancer Res Clin Oncol"},{"key":"3699_CR19","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","volume":"21","author":"NJ Vogelzang","year":"2003","unstructured":"Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P et al (2003) Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21:2636\u20132644","journal-title":"J Clin Oncol"},{"key":"3699_CR20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/ejcts\/ezaa363","volume":"59","author":"DA Waller","year":"2021","unstructured":"Waller DA, Opitz I, Bueno R, Van Schil P, Cardillo G, Harpole D et al (2021) Divided by an ocean of water but united in an ocean of uncertainty: a transatlantic review of mesothelioma surgery guidelines. Eur J Cardiothorac Surg 59:8\u201311","journal-title":"Eur J Cardiothorac Surg"},{"key":"3699_CR21","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/S0140-6736(15)01238-6","volume":"387","author":"G Zalcman","year":"2016","unstructured":"Zalcman G, Mazieres J, Margery J, Greillier L, Audigier-Valette C, Moro-Sibilot D et al (2016) Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial. Lancet 387:1405\u20131414","journal-title":"Lancet"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-021-03699-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-021-03699-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-021-03699-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T03:29:28Z","timestamp":1650338968000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-021-03699-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,29]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["3699"],"URL":"https:\/\/doi.org\/10.1007\/s00432-021-03699-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-299157\/v1","asserted-by":"object"}]},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,29]]},"assertion":[{"value":"23 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"TK received honoraria for AstraZeneca Co. LTD, and Ono Pharmaceutical Co., LTD. MN received honoraria for Daiichi Sankyo Company and Eisai Japan Co and received a research grant from Eisai Japan Co. All other authors declared no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The present protocol was approved by the Kanazawa University Institutional Review Board (IRB) (reference number 2750-2), Kanazawa Medical University (I328), and the IRBs at Hokushin Ganpro database project, all of which granted a waiver of consent for the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}